INNOVENT BIOLOGICS INC revenue breakdown overview

INNOVENT BIOLOGICS INC revenue for the last year amounted to 6.83 B HKD, the most of which — 6.86 B HKD — came from its highest performing source at the moment, Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development, the year earlier bringing 5.30 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought INNOVENT BIOLOGICS INC 6.36 B HKD, and the year before that — 4.81 B HKD.